Illumina, Inc. (NASDAQ: ILMN) Q4 2020 earnings call dated Feb. 11, 2021 Corporate Participants: Juliet Cunningham — Vice President, Investor Relations Francis deSouza — President & Chief Executive Officer Sam Samad — Senior Vice President & Chief Financial Officer Analysts: Daniel Brennan — UBS — Analyst Tycho W. Peterson — J.P. Morgan — Analyst Doug Schenkel — Cowen and Company — Analyst Puneet Souda — SVB Leerink Partners —...
Illumina, Inc. (ILMN) Q4 2020 Earnings Call Transcript
Tags: Diagnostics & Research
Related Post
- MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings…
-
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat…
-
Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance
Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter…